Pain reliever offers prescribing flexibility

Nov. 1, 1996
UCB Pharma, Inc. has received approval from the U.S. Food and Drug Administration to market Lortab 10/500 CIII (Hydrocodone* Bitartrate and Acetaminophen Tablets, USP, 10 mg/500 mg, *Warning: May be habit-forming). The new addition to the Lortab brand line of pain relievers offers American doctors the first 10 mg hydrocodone combination, formulated to maximize therapeutic flexibility and minimize the potential for acetaminophen (APAP) toxicity. The 500 mg APAP content is lower than that of any o

UCB Pharma, Inc. has received approval from the U.S. Food and Drug Administration to market Lortab 10/500 CIII (Hydrocodone* Bitartrate and Acetaminophen Tablets, USP, 10 mg/500 mg, *Warning: May be habit-forming). The new addition to the Lortab brand line of pain relievers offers American doctors the first 10 mg hydrocodone combination, formulated to maximize therapeutic flexibility and minimize the potential for acetaminophen (APAP) toxicity. The 500 mg APAP content is lower than that of any other 10 mg hydrocodone combination. Suggested dosing of one tablet every four to six hours does not exceed the generally recommended, maximum acetaminophen dose of 4000 mg/day. Like other products in the growing Lortab brand line that it complements, Lortab 10/500 provides analgesic relief in minutes that lasts for hours, with onset of action in 10-30 minutes, and duration from four to six hours. The toleration profile is similar to other narcotic analgesics, with light-headedness and sedation among the most frequently reported adverse effects.

For additional information, circle the number below.

UCB PHARMA, INC.

Sponsored Recommendations

How to choose your diagnostic imaging technology

If any car could take you from A to B, what made you choose the one you’re driving? Once you determine your wants and needs, purchasing decisions become granular regarding personal...

A picture is worth a thousand words - Increase case acceptance with dental technology

How can you strengthen case acceptance at your practice? One way is by investing in advanced technology that enables you to make a stronger case for treatment and to provide faster...

Discover technology solutions to improve case acceptance

Case acceptance is central to the oral health of your patients and the financial health of your practice. Click here to discover how the right investments in technology can help...

What to expect when you invest in equipment and technology

Hear from 3 seasoned Patterson representatives as they share their firsthand knowledge of what an investment in equipment and technology means to a practice.